Skip to content
lifitegrast

Structure via PubChem · Public domain (PubChem)

EntityQ23044263· pop 12· linked from 15 articles

lifitegrast

Sign in to save

Also known as compound 1g [PMID: 24900456], SAR 1118, SAR-1118, SAR-1118-023, Xiidra®, SAR1118

Lifitegrast, sold under the brand name Xiidra (), is a medication for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. It is often used as an alternative to ciclosporin (Ikervis, Restasis, Vevye, Verkazia or Cequa) for dry eye treatment including meibomian gland dysfunction and inflammatory dry eye.

Key facts

Drug.ChEBI
133023
Drug.ChEMBL
2048028
Drug.image
Lifitegrast skeletal.svg
Drug.image_class
skin-invert-image
Drug.tradename
Xiidra
Drug.MedlinePlus
a616039
Drug.pregnancy_AU
B1
Drug.routes_of_administration
Eye drops
Drug.ATC_prefix
S01
Drug.ATC_suffix
XA25
Drug.legal_AU
S4
Drug.legal_CA
Rx-only
Drug.legal_US
Rx-only
Drug.CAS_number
1025967-78-5
Drug.PubChem
11965427
Drug.DrugBank
DB11611
Drug.ChemSpiderID
10139520
Drug.UNII
038E5L962W

via Wikipedia infobox

Chemical data

Formula
C29H24Cl2N2O7S
Molecular weight
615.5 g/mol
IUPAC name
(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid
SMILES
CS(=O)(=O)C1=CC=CC(=C1)C[C@@H](C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl
InChIKey
JFOZKMSJYSPYLN-QHCPKHFHSA-N
XLogP
4.7
Polar surface area
142 Ų
H-bond donors
2
H-bond acceptors
7
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
First approval
2016
Admin. routes
topical
Indications
dry eye syndrome, allergic conjunctivitis, eye disease, graft versus host disease

via ChEMBL · EBI

Research

165 papers

via PubMed

Wikidata facts

Mass
614.068127
Has use
medication
Show 5 more facts
chemical formula
C₂₉H₂₄Cl₂N₂O₇S
canonical SMILES
CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl
isomeric SMILES
CS(=O)(=O)C1=CC(C[C@H](NC(=O)C2=C(Cl)C3=C(CN(CC3)C(=O)C4=CC5=C(C=CO5)C=C4)C=C2Cl)C(O)=O)=CC=C1
subject has role
eye drop
Commons category
Lifitegrast
Sources (2)

via Wikidata · CC0

~4 min read

Encyclopedic overview

5 sections
Contents
  • Adverse effects
  • Pharmacology
  • Mechanism of action
  • History
  • References

{{Infobox drug | image = Lifitegrast skeletal.svg | image_class = skin-invert-image | alt = | caption =

| pronounce = | tradename = Xiidra | Drugs.com = | MedlinePlus = a616039 | pregnancy_AU = B1 | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = Eye drops | ATCvet = | ATC_prefix = S01 | ATC_suffix = XA25

Excerpted from Wikipedia’s “lifitegrast” article, available under the CC BY-SA 4.0 licence.